Harriet Wikman
Overview
Explore the profile of Harriet Wikman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
3360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Reimer F, Bryan S, Legler K, Karn T, Eppenberger-Castori S, Matschke J, et al.
Cancer Cell Int
. 2023 Mar;
23(1):47.
PMID: 36927383
Background: The disruption of epithelial features represents a critical step during breast cancer spread. In this context, the dysregulation of desmosomal proteins has been associated with malignant progression and metastasis...
12.
Abdo M, Belloum Y, Heigener D, Welker L, von Weihe S, Schmidt M, et al.
Mol Oncol
. 2023 Mar;
17(5):737-746.
PMID: 36892210
Alternative sources of tumour information need to be explored in patients with non-small cell lung cancer (NSCLC). Here, we compared programmed cell death ligand 1 (PD-L1) expression on cytology imprints...
13.
Nitschke C, Markmann B, Walter P, Badbaran A, Tolle M, Kropidlowski J, et al.
Clin Chem
. 2023 Jan;
69(3):295-307.
PMID: 36644936
Background: KRAS circulating tumor DNA (ctDNA) has shown biomarker potential for pancreatic ductal adenocarcinoma (PDAC) but has not been applied in clinical routine yet. We aim to improve clinical applicability...
14.
Nitschke C, Markmann B, Konczalla L, Kropidlowski J, Pereira-Veiga T, Scognamiglio P, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36428523
Background: Circulating Cancer Associated Macrophage-like cells (CAMLs) have been described as novel liquid biopsy analytes and unfavorable prognostic markers in some tumor entities, with scarce data for Pancreatic Ductal Adenocarcinomas...
15.
Westphal M, Pantel K, Ricklefs F, Maire C, Riethdorf S, Mohme M, et al.
Neurooncol Adv
. 2022 Nov;
4(Suppl 2):ii45-ii52.
PMID: 36380859
For many tumor entities, tumor biology and response to therapy are reflected by components that can be detected and captured in the blood stream. The so called "liquid biopsy" has...
16.
Piffko A, Asey B, Duhrsen L, Ristow I, Salamon J, Wikman H, et al.
Front Oncol
. 2022 Nov;
12:951805.
PMID: 36338751
Non-small cell lung cancer (NSCLC) is currently the leading cause of cancer-related death worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously increasing. The recent improvements...
17.
Nitschke C, Markmann B, Tolle M, Kropidlowski J, Belloum Y, Goetz M, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139565
Background: In pancreatic ductal adenocarcinoma (PDAC), the characterization of circulating tumor cells (CTCs) opens new insights into cancer metastasis as the leading cause of cancer-related death. Here, we focused on...
18.
Pereira-Veiga T, Schneegans S, Pantel K, Wikman H
Cell Rep
. 2022 Aug;
40(9):111298.
PMID: 36044866
Circulating tumor cells (CTCs) are the seeds of distant metastasis, and the number of CTCs detected in the blood of cancer patients is associated with a worse prognosis. CTCs face...
19.
Leffers M, Herbst J, Kropidlowski J, Prieske K, Bohnen A, Peine S, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010947
Cervical cancer is the fourth most common cancer in women, which is associated in >95% with a high-risk human papillomavirus (HPV) infection. Methylation of specific genes has been closely associated...
20.
Herbst J, Pantel K, Effenberger K, Wikman H
Br J Cancer
. 2022 Jun;
127(8):1403-1410.
PMID: 35725812
Human papilloma virus (HPV) is an infectious carcinogenic agent. Nearly all cervical cancers are positive for one of the high-risk HPV subtypes. Although the introduction of the HPV vaccines in...